At the time of writing, PAVmed Inc [PAVM] stock is trading at $0.47, up 6.26%. An important factor to consider is whether the stock is rising or falling in short-term value. The PAVM shares have lost -9.44% over the last week, with a monthly amount drifted -10.66%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
PAVmed Inc [NASDAQ: PAVM] stock has seen the most recent analyst activity on March 30, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $8. Previously, Ascendiant Capital Markets started tracking the stock with Buy rating on November 05, 2020, and set its price target to $5. On June 28, 2018, Maxim Group initiated with a Buy rating and assigned a price target of $5 on the stock.
For the past year, the stock price of PAVmed Inc fluctuated between $0.30 and $1.90. PAVmed Inc [NASDAQ: PAVM] shares were valued at $0.47 at the most recent close of the market.
Analyzing the PAVM fundamentals
According to PAVmed Inc [NASDAQ:PAVM], the company’s sales were 1.02M for trailing twelve months, which represents an -99.39% plunge. Gross Profit Margin for this corporation currently stands at -5.06% with Operating Profit Margin at -675.39%, Pretax Profit Margin comes in at -1745.58%, and Net Profit Margin reading is 10.39%. To continue investigating profitability, this company’s Return on Assets is posted at 1.66, Equity is 3.62 and Total Capital is -141.89. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of228.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4400 points at the first support level, and at 0.4101 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4899, and for the 2nd resistance point, it is at 0.5099.
Ratios To Look Out For
It is important to note that PAVmed Inc [NASDAQ:PAVM] has a current ratio of 0.52. On the other hand, the Quick Ratio is 0.52, and the Cash Ratio is 381.12. Considering the valuation of this stock, the price to sales ratio is 9.96, the price to book ratio is 0.73 and price to earnings (TTM) ratio is 0.40.
Transactions by insiders
Recent insider trading involved JAMES L. COX, Director, that happened on Dec 12 ’24 when 9469.0 shares were purchased. Director, JAMES L. COX completed a deal on Dec 09 ’24 to buy 38095.0 shares. Meanwhile, Director JAMES L. COX bought 15600.0 shares on Dec 06 ’24.
